AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...
Across 24 peaks and 240 miles through the Sierra Nevada, a UC Davis team searches for high-altitude Jeffrey pines to learn ...